Ro Khanna (D-CA)

Prescription Drug Price Relief Act of 2025

H.R. 3546 · House bill Health

A Democratic bill with 4 Democratic cosponsors · See all 4 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Prescription Drug Price Relief Act of 2025 aims to lower drug prices by ending government-granted monopolies for drugs priced higher than the median in other countries. The Secretary of Health and Human Services will review brand name drugs annually to determine if prices are excessive based on international price comparisons or other specific factors. If a drug is deemed excessively priced, the Secretary will waive its exclusivities and grant open, non-exclusive licenses to allow others to manufacture or import the drug. The bill also mandates that entities accepting these licenses pay a reasonable royalty to the patent holder. Additionally, the Act requires manufacturers to submit detailed annual reports regarding drug pricing, research costs, and revenues.

Yes· 3 of 8

  • Scored +10

    Does this lower the price of prescription medicines?

    The bill specifically targets and aims to significantly lower the costs of brand name drugs through competition.

  • Scored +8

    Would households on low incomes be better off under this?

    Lower drug prices provide significant relief to low-income households.

  • Scored +7

    Does this give people more protection from unfair business practices?

    The bill enhances consumer protection by introducing competition to lower drug prices.

The opposite

  • Scored -6

    Does this make patent and copyright rules fairer?

    The bill reduces exclusivity rights for patent holders to lower drug prices.